Paperpal Prime Logo

Clinical Drug Investigation : Impact Factor & More

eISSN: 1179-1918pISSN: 1173-2563

Key Metrics

CiteScore
5.2
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.02
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical Drug Investigation

Clinical Drug Investigation Journal Specifications

Overview
Publisher ADIS INT LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Clinical Drug Investigation ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical Drug Investigation

Cost Effectiveness of Teriparatide for Postmenopausal Osteoporosis: A Systematic Review.
  • 8 Aug 2026
  • Clinical drug investigation
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.
  • 1 Aug 2026
  • Clinical drug investigation
Pigmentary Changes Reported with Tyrosine Kinase Inhibitors: A Narrative Review of Mechanisms and Clinical Implications.
  • 1 Aug 2026
  • Clinical drug investigation
Ketamine and Evolving Neuroplasticity.
  • 1 Aug 2026
  • Clinical drug investigation
Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants.
  • 1 Aug 2026
  • Clinical drug investigation
Deuruxolitinib: New Approval.
  • 1 Aug 2026
  • Clinical drug investigation
Cost Effectiveness of Teriparatide for Postmenopausal Osteoporosis: A Systematic Review.
  • 8 Aug 2026
  • Clinical drug investigation
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.
  • 1 Aug 2026
  • Clinical drug investigation
Pigmentary Changes Reported with Tyrosine Kinase Inhibitors: A Narrative Review of Mechanisms and Clinical Implications.
  • 1 Aug 2026
  • Clinical drug investigation
Ketamine and Evolving Neuroplasticity.
  • 1 Aug 2026
  • Clinical drug investigation
Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants.
  • 1 Aug 2026
  • Clinical drug investigation
Deuruxolitinib: New Approval.
  • 1 Aug 2026
  • Clinical drug investigation

FAQs on Clinical Drug Investigation